A carregar...
CDK4/6 inhibitors: The mechanism of action may not be as simple as once thought
CDK4/6 inhibitors are among a new generation of therapeutics. Building upon the striking success of the combination of CDK4/6 inhibitors and the hormone receptor antagonist letrozole in breast cancer, many other combinations have recently entered clinical trials in multiple diseases. To achieve maxi...
Na minha lista:
| Publicado no: | Cancer Cell |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6039233/ https://ncbi.nlm.nih.gov/pubmed/29731395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2018.03.023 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|